Biotechnology Stocks I Performance Guide: Akero Therapeutics, Inc. (AKRO)
AKRO has no dividends.
Table and Chart of AKRO Performance
See what a $1,000 investment in AKRO is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| AKRO Returns | |
|---|---|
| Start Date | Jul-31-2019 |
| Start Price | $24.20 |
| End Date | Oct-09-2024 |
| End Price | $28.51 |
| # Prices | 64 |
| Min Date | May-31-2022 |
| Min Price | $8.64 |
| Max Date | Dec-30-2022 |
| Max Price | $54.80 |
| Total Return | 17.81% |
| Annualized Return | 3.12% |
| Current Value of $1,000 Purchase | $1,178 |
| Number Returns | 2,016 |
| Average Return | 26.49% |
| Number Profitable Returns | 1,080 |
| Percent Profitable Returns | 53.57% |
| Number Unprofitable Returns | 936 |
| Percent Unprofitable Returns | 46.43% |
| Profitable to Unprofitable Returns Ratio | 1.15 |
| AKRO Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -6.770 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -234174000 |
| PE to Growth Ratio | None |
| Price to Book | - |
| PRICE DATA | |
| 52 Week High | $-0.257 |
| 52 Week Low | $37 |
| Analyst Target Price | $0 |
| 50-Day Moving Average | $11.25 |
| 200-Day Moving Average | $26.58 |
| FINANCIAL DATA | |
| Revenue per Share | $-3.44 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -19.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
AKRO Compare Returns with S&P 500
AKRO Trendline Chart
AKRO Moving Average Chart
AKRO Stock Return Map - See Patterns of Gains and Losses
AKRO Stock Returns/Purchase Dates